Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slid 1.16% to $66.51 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.85% to 3,918.32 and Dow Jones Industrial Average falling 1.66% to 32,254.86. This was the stock's fourth consecutive day of losses. Bristol Myers Squibb Co. closed $14.93 below its 52-week high ($81.44), which the company reached on December 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 1.12% to $151.24, Pfizer Inc. (PFE) fell 1.65% to $39.46, and Abbott Laboratories (ABT) fell 1.56% to $97.85. Trading volume (7.6 M) remained 240,530 below its 50-day average volume of 7.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 9, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 09, 2023 16:41 ET (21:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.